Epigentek is an epigenetics company specialized in epigenetic kits and reagents (antibodies, etc…), as well as in services for epigenetic research (DNA methylation, histone modification, chromatin studies, etc…).
Epigentek – epigenetic products and services
Epigentek is a world-leading provider of epigenetic-related products and services. Epigentek products are specifically designed to make assays much simpler, faster, more convenient, and highly more efficient than currently used methods. For instance, EpiQuik Histone H3 Modification Multiplex Assay Kit is a complete tool to detect and quantify up to 21 modified histone H3 patterns simultaneously in an ELISA-like format using a standard microplate reader. Furthermore, the EpiQuik Histone H4 Modification Multiplex Assay Kit allows the detection and quantification nearly all histone H4 modifications (10 different PTMs). Moreover, Epigentek also proposes the EpiSonic 2000 Sonication System, with an integrated cooling for DNA and chromatin shearing applications.
Additionally, Epigentek offers a comprehensive service packages to address all aspects of epigenetic research, including histone modification, DNA methylation, chromatin remodeling, and non-coding RNA studies. Epigentek provides genome-wide DNA methylation analysis, like Bisulfite-based DNA methylation sequencing (Methyl-Seq), MeDIP-based DNA methylation sequencing (MeDIP-Seq), Methylation-Specific PCR, Global 5-mC Quantification, etc… Furthermore, Epigentek’s platforms for ChIP-seq or ChIP-qPCR allow researchers to make the most of its chromatin studies with minimal sequencing bias. Epigentek also proposes its proprietary antibody validation service to ensure that an antibody is suitable for ChIP-PCR, ChIP-on-chip or ChIP-seq. Moreover, Epigentek is one of the first biotech company offering epigenetic-oriented drug discovery services. This Drug Discovery Screening service is based on highly trained scientists with strong expertise in assay design, sample processing, experimental procedures, and data analysis. Epigentek has a wide panel of epigenetic enzymes and modifications to establish how selective a compound is to its intended targets. Indeed, Epigentek proposes the Epigenase Epigenetic Enzyme Inhibitor Screening Service (including DNMT profiling, HDMT profiling, HMT profiling, HAT profiling, bromodomain profiling and HDAC profiling) as well as the EpiModifier Epigenetic Histone Modification Profiling (including DNA demethylation profiling, DNA methylation profiling, histone methylation profiling, histone acetylation profiling, histone SUMOylation profiling, histone phosphorylation profiling, etc…).
Founded in 2005 in the USA, Epigentek Group Inc. is a leading developer and provider of innovative technologies for epigenetic-related research. Epigentek’s products are sold worldwide through a global network of distributors in more than thirty six countries.
More about Epigentek: www.epigentek.com